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  TSAA－291 （16B－ethyl－17G－hydroxy－4－estren－S－one） was administered intramuscUlarly 2 vials
（400 mg） a week for 12 weeks to 45 cases of benign prostatic hypertrophy． A considerable reduction
of the prostatic weight was observed in 21 cases （580／o） on measurement using transrectal ultrasono－
tomography． ln 5 cases （110／）） of them， the prostate enlarged on the contrary． ln the remaining
14 cases （310／．）， no remarkable change was noticed on the weight． Some improvement of subjective
symptoms and residual urine volume were recognized after the administration of TSAA－291 i．n almost
all the cases． No serious complication occurred．
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  Fig． 1． TSAA－291
d「oxy－4－estren－3－oneである．作用は主としてandro－
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Case NTo． 11 （cm／gauge）．










           Before After
Fig． 5． Ultrasonotomograms of the prostate before and after TSAA－291 treatment in
Case No． 13 （cm／gauge）．
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           Before After
Fig． 7． Ultrasonotomograms of the prostate before and after TSAA－291
       Case No． 18 （cm／gauge）．
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    Before AfterUltrasonotomograms of the prostate before and after TSAA－291









           Before After
Fig． 9． Ultrasonotomograms of the prostate before and after TSAA－291
       Case No． 32 （cm／gauge）．
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treatment and change rates of prostatic
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Fig． I l． Ages and change rates of prostatic
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